INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 27 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 74,566 | $116,000 | 0.11% |
| IMS Capital Management | 29,291 | $45,000 | 0.04% |
| Paulson Wealth Management Inc. | 11,250 | $17,000 | 0.01% |
| Next Capital Management LLC | 1,139 | $2,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 4,782 | $7,000 | 0.00% |
| Renaissance Technologies | 381,082 | $591,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 181 | $0 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,000 | $39,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 75 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 40 | $0 | 0.00% |